Labgenomics Plans 1 Billion Won Share Buyback

• Labgenomics plans to buy back 613,496 common shares for 1 billion won.
• Purchases will run from Oct. 26, 2026, through Jan. 22, 2027, on the Kosdaq market to enhance shareholder value.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labgenomics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000138), on October 23, 2026, and is solely responsible for the information contained therein.